Palisade Bio Correlations
| PALI Stock | USD 1.50 0.08 5.06% |
The current 90-days correlation between Palisade Bio and Leap Therapeutics is -0.08 (i.e., Good diversification). The correlation of Palisade Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Palisade Bio Correlation With Market
Very good diversification
The correlation between Palisade Bio and DJI is -0.29 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and DJI in the same portfolio, assuming nothing else is changed.
Moving against Palisade Stock
| 0.48 | JUMP | Leveljump Healthcare Corp | PairCorr |
| 0.36 | ALT | Altimmune | PairCorr |
| 0.34 | RNAZ | Transcode Therapeutics | PairCorr |
| 0.34 | AVCR | Avricore Health | PairCorr |
| 0.51 | KB | KB Financial Group Earnings Call This Week | PairCorr |
| 0.48 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
| 0.46 | MFG | Mizuho Financial | PairCorr |
| 0.46 | CVX | Chevron Corp | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Palisade Stock performing well and Palisade Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Palisade Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ASBP | 8.45 | (2.77) | 0.00 | 2.02 | 0.00 | 19.52 | 66.08 | |||
| CRIS | 4.04 | (0.56) | 0.00 | (0.19) | 0.00 | 10.62 | 33.70 | |||
| ENTO | 7.46 | (0.02) | 0.00 | 0.10 | 0.00 | 16.86 | 39.61 | |||
| PCSA | 8.29 | (0.77) | 0.00 | (8.24) | 0.00 | 11.68 | 164.28 | |||
| BCTX | 6.82 | (0.79) | 0.00 | (0.86) | 0.00 | 13.96 | 98.43 | |||
| HOTH | 2.57 | (0.95) | 0.00 | (0.93) | 0.00 | 4.81 | 13.69 | |||
| LPTX | 14.85 | 5.08 | 0.64 | 0.35 | 6.90 | 25.00 | 65.13 | |||
| CTXR | 4.61 | (1.06) | 0.00 | (0.36) | 0.00 | 10.59 | 38.23 | |||
| DARE | 3.06 | (0.22) | 0.00 | (0.09) | 0.00 | 6.55 | 26.52 | |||
| ATHA | 4.12 | 0.61 | 0.10 | (0.47) | 4.10 | 6.70 | 71.83 |
Palisade Bio Corporate Management
| James MD | VP Development | Profile | |
| Joerg Heyer | Head Medicine | Profile | |
| Ryker Willie | Senior Controller | Profile | |
| Sharon McBrayer | Director Operations | Profile | |
| Sharon Skare | Vice Operations | Profile |